Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) Enterprise Value (2016 - 2026)

Healthequity (HQY) has 13 years of Enterprise Value data on record, last reported at -$309.3 million in Q4 2025.

  • For Q4 2025, Enterprise Value rose 4.01% year-over-year to -$309.3 million; the TTM value through Oct 2025 reached -$309.3 million, up 4.01%, while the annual FY2025 figure was -$295.9 million, 26.74% up from the prior year.
  • Enterprise Value reached -$309.3 million in Q4 2025 per HQY's latest filing, down from -$304.5 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$161.2 million in Q2 2022 and bottomed at -$753.8 million in Q3 2021.
  • Average Enterprise Value over 5 years is -$342.4 million, with a median of -$300.2 million recorded in 2025.
  • Peak YoY movement for Enterprise Value: tumbled 330.63% in 2021, then soared 78.11% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$649.1 million in 2021, then skyrocketed by 67.62% to -$210.2 million in 2022, then tumbled by 58.93% to -$334.1 million in 2023, then grew by 3.56% to -$322.2 million in 2024, then grew by 4.01% to -$309.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$309.3 million in Q4 2025, -$304.5 million in Q3 2025, and -$287.9 million in Q2 2025.